# A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

> **NCT00659269** · PHASE3 · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 319 (actual)

## Conditions studied

- Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Multivitamin (MV)
- **DIETARY_SUPPLEMENT:** Multivitamin + Vitamin B12 + Vitamin B6
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT00659269
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2013-06
- **Final completion:** 2015-06
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2016-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659269, "A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00659269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*